Monika Davare
12PUBLICATIONS
72CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (12)
Sort by Publication Date:
|May 09, 2025
Ribociclib in Sequential Combination with Doxorubicin in Anthracycline-Naïve Advanced Soft-Tissue Sarcomas: Results of a Dose-Finding Phase Ib Study.Lara E Davis, Limin Zhu, Emile Latour
|Feb 18, 2025
Pan-Cancer Analysis of Oncogenic MET Fusions Reveals Distinct Pathogenomic Subsets with Differential Sensitivity to MET-Targeted Therapy.Christopher A Febres-Aldana, Morana Vojnic, Igor Odintsov
|Jan 31, 2024
TKI Type Switching Overcomes ROS1 L2086F in ROS1 Fusion-Positive Cancers.Rajat Thawani, Matteo Repetto, Clare Keddy
|Oct 09, 2023
Author Correction: Vepafestinib is a pharmacologically advanced RET-selective inhibitor with high CNS penetration and inhibitory activity against RET solvent front mutations.Isao Miyazaki, Igor Odintsov, Keiji Ishida
|Sep 24, 2023
Vepafestinib is a pharmacologically advanced RET-selective inhibitor with high CNS penetration and inhibitory activity against RET solvent front mutations.Isao Miyazaki, Igor Odintsov, Keiji Ishida
|Aug 17, 2023
Discovery of oncogenic ROS1 missense mutations with sensitivity to tyrosine kinase inhibitors.Sudarshan R Iyer, Kevin Nusser, Kristen Jones
Pageof 2
Frequent Collaborators
3 joint publications
Romel Somwar
3 joint publications
Alexander Drilon
2 joint publications
Morana Vojnic
2 joint publications
Florence Choo
2 joint publications
Lara E Davis
2 joint publications
Masanori Kato
2 joint publications
Allan J W Lui
2 joint publications
Marc Ladanyi
2 joint publications
Catherine Z Beach
2 joint publications
Clare Keddy
